RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer
- PMID: 38917876
- DOI: 10.1016/j.semcancer.2024.06.001
RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer
Erratum in
-
Erratum to "RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer" [Semin. Cancer Biol. 102-103 (2024) 4-16].Semin Cancer Biol. 2024 Nov;106-107:13-14. doi: 10.1016/j.semcancer.2024.08.005. Epub 2024 Aug 28. Semin Cancer Biol. 2024. PMID: 39208470 No abstract available.
Abstract
Epithelial-mesenchymal transition (EMT) is a major contributor to metastatic progression and is prominently regulated by TGF-β signalling. Both EMT and TGF-β pathway components are tightly controlled by non-coding RNAs - including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) - that collectively have major impacts on gene expression and resulting cellular states. While miRNAs are the best characterised regulators of EMT and TGF-β signaling and the miR-200-ZEB1/2 feedback loop plays a central role, important functions for lncRNAs and circRNAs are also now emerging. This review will summarise our current understanding of the roles of non-coding RNAs in EMT and TGF-β signaling with a focus on their functions in cancer progression.
Keywords: CircRNA; EMT; LncRNA; MiR-200; MiRNA; TGF-β.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there are no conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
